The agreement was signed yesterday in Berlin by Dr. Rose Goldstein, Vice-Principal (Research and International Relations) of McGill University, and Prof. Peter-André Alt, President of Freie Universität Berlin. Led by Prof. Gerhard Multhaup, Chair of McGill’s Department of Pharmacology and Therapeutics, and Profs. Rainer Müller and Rainer Haag from Freie Universität’s Department of Biology, Chemistry, and Pharmacy, the research collaboration will initially focus on disorders of brain function.

“We are pleased to expand our existing relationship with Freie Universität Berlin, a leading institution with an impressive record in interdisciplinary research and international collaborations,” said Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill. “Our two universities are strong contributors to the innovation capacity and competitiveness of our respective countries, and through this agreement we at McGill are delighted to provide further international opportunities for Canadian students and researchers.”

“It is the strategy of Freie Universität to build inspiring international networks for our researchers. This agreement will enable our institutions to cooperate more closely in promoting young researchers and in advancing joint research initiatives,” said President Alt of Freie Universität Berlin.

The agreement was signed during a visit by representatives of Canada’s 15 leading research-intensive universities to mark the 40th anniversary of the Germany Canada Agreement on Cooperation in Science and Technology.